[Gene therapy for restenosis after angioplasty].
Aoki
Motokuni
M
Department of Geriatric Medicine, Osaka University Graduate School of Medicine.
Ogihara
Toshio
T
Morishita
Ryuichi
R
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000818:Animals; D018797:Cell Cycle Proteins; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000628:therapy; D023903:Coronary Restenosis / Q000209:etiology / Q000628:therapy*; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D016228:Endothelial Growth Factors; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D016328:NF-kappa B; D014157:Transcription Factors; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D016328:NF-kappa B; D014157:Transcription Factors; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors